Header Logo

Connection

Laura Holman to Indazoles

Back to Details
This is a "connection" page, showing publications Laura Holman has written about Indazoles.
Laura Holman
Connection Strength
0.229
Indazoles
  1. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial. Ann Oncol. 2024 Nov; 35(11):981-992.
    View in: PubMed
    Score: 0.229
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.